News

All news

2020-03-09

ACCORD HEALTHCARE LAUNCH ATAZANAVIR

Accord Healthcare is delighted to announce the launch of Atazanavir 200 mg x 60 capsules and 300 mg x 30 capsules.   

This medicine, co-administered with low dose ritonavir, is indicated for the treatment of HIV-1 infected adults and paediatric patients 6 years of age and older in combination with other antiretroviral medicinal products.

Please refer to the Summary of Product Characteristics (SPC) for further information. The SPC is available from www.hpra.ie or here for Healthcare Professionals. 

For further information please contact Accord in Cork on 021-461 9040.

Date of Preparation: December 2019. IE-01464

 

 

All news